SCHEMBL7397194

SCHEMBL7397194

Nc1ccc2c(c1)CN(CCc1ccccc1)C(=O)C(CC(=O)OCc1ccccc1)N2

nearest known ligand 0.54

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 19/20 0.54
ITGA2B P08514 16/20 0.54
ITGAV P06756 5/20 0.54
GLA P06280 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7397693 0.82 ITGB3 (0.65) ITGB3ITGA2BITGAV
SCHEMBL7397691 0.82 ITGB3 (0.65) ITGB3ITGA2BITGAV
SCHEMBL7395210 0.82 ITGB3 (0.65) ITGB3ITGA2BITGAV
SCHEMBL7395216 0.82 ITGB3 (0.65) ITGB3ITGA2BITGAV
SCHEMBL7397826 0.80 GLA (0.38) ITGB3ITGA2BITGAVGLA
SCHEMBL7338314 0.80 ITGB3 (0.52) ITGB3ITGA2BITGAV
SCHEMBL7398783 0.79 ITGB3 (0.47) ITGB3ITGA2BITGAV
SCHEMBL6674672 0.77 ITGB3 (0.71) ITGB3ITGA2BITGAV
SCHEMBL6674674 0.77 ITGB3 (0.71) ITGB3ITGA2BITGAV
SCHEMBL7079853 0.77 ITGB3 (0.71) ITGB3ITGA2BITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0593603-B1 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2002-11-20 EP disclosed
US-6127359-A Bicyclic fibrinogen antagonists SMITHKLINE BEECHAM CORPORATION (US) 2000-10-03 US disclosed
US-5939412-A Bicyclic fibrinogen antagonists SMITHKLINE BEECHAM CORPORATION (US) 1999-08-17 US disclosed
US-5693636-A Bicyclic fibrinogen antagonists SMITHKLINE BEECHAM CORPORATION (US) 1997-12-02 US disclosed
EP-0593603-A1 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1994-04-27 EP disclosed
WO-1993000095-A2 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1993-01-07 WO disclosed